In the lead up to the BIO Conference 2006, delegates are being invited to attend Bootcamp, a series of full-day workshops being held around Australia on negotiating technology deals.

Chris Weaver has resigned as Medical Developments Internationa (ASX:MVP) managing director and CEO to take up an executive management position with a bank. Current CFO Jeremy Payling will act as interim CEO while the company searches for a new CEO.

State government policy has been vital in helping to shape the Australian biotechnology industry. Here, Cristy Burne takes us for a tour of Western Australia, the state that later this year will host the national biotech conference.

Brisbane RNAi gene therapy company Benitec (ASX:BLT) has granted a global, non-exclusive licence for its gene-silencing technology to a German company that develops genetically modified mice for research.

Australia is home to a thriving and dynamic biotechnology industry with a firm footing in the world-class research base found in the universities and research institutions 'Down Under'.

An Australian company will soon be offering genetically altered rodents modified at the single-cell stage to maximise efficiencies.